The aim of this study was to explore whether single-wall carbon nanotubes (SWCNTs) can be used as artery tissue-engineering materials by promoting vascular adventitial fibroblasts (VAFs) to transform into myofibroblasts (MFs) and to find the signal pathway involved in this process. VAFs were primary cultured and incubated with various doses of SWCNTs suspension (0, 0.8, 3.2, 12.5, 50, and 200 µg/mL). In the present study, we used three methods (MTT, WST-1, and WST-8) at the same time to detect the cell viability and immunofluorescence probe technology to investigate the effects of oxidative injury after VAFs incubated with SWCNTs. Immunocytochemical staining was used to detect SM 22 -α expression to confirm whether VAFs transformed into MFs. The protein levels were detected by western blotting. The results of immunocytochemical staining showed that SM 22 -α was expressed after incubation with 50 µg/mL SWCNTs for 96 hours, but with oxidative damage. The mRNA and protein levels of SM 22 -α, C-Jun N-terminal kinase, TGF-β 1 , and TGF-β receptor II in VAFs increased with the dose of SWCNTs. The expression of the p-Smad2/3 protein was upregulated while the Smad7 protein was significantly down-regulated. Smad4 was translocated to the nucleus to regulate SM 22 -α gene expression. In conclusion, SWCNTs promoted VAFs to transform into MFs with SM 22 -α expression by the C-Jun N-terminal kinase/Smads signal pathway at the early stage (48 hours) but weakened quickly. SWCNTs also promoted the transformation by the TGF-β l /Smads signal pathway at the advanced stage in a persistent manner. These results indicate that SWCNTs can possibly be used as artery tissue-engineering materials.
Introduction
Nanotechnology is the understanding and control of matter at dimensions of roughly 1 to 100 nanometers, where unique phenomena enable novel applications. The application of nanotechnology in medicine has potential in a range of treatments, including gene therapy, 1 drug delivery, 2 and medical devices. 3 However, turning the early promise into readily available medical treatments is a lengthy process, involving the development of the products efficacy, safety, stability, manufacture, and regulation. The tissueengineering nanomaterials, which are produced from traditional tissue-engineering materials by nanotechnology, have special biological properties and have attracted much interest. In recent years, studies on the application of nanomaterials [4] [5] [6] [7] [8] [9] [10] [11] [12] in tissue engineering fields have been of great interest. The applications of nanophase ceramics, carbon nanotubes (CNTs), carbon nanowires, and nano metallic materials in bone and cartilage tissue engineering; titanium nanomaterials, 4 poly-DL-lactide nanomaterials, [5] [6] [7] [8] and carbon nanofibers 9, 10 in artery tissue engineering; organic frameworks, 11 nanofibrous scaffolds, and CNTs/fibers in neural tissue engineering; 12 and nanostructured polymers in bladder tissue engineering have already been reported. These reports indicate that nanomaterials, especially CNTs, have potential in further applications.
The simplest type of CNT is the single-walled CNT (SWCNT) which can be thought of as a single sheet of graphite rolled up to form a seamless cylinder. The theoretical volume for discrete SWCNT has been estimated as 1300 m 2 /g. The large surface area provides the membrane basal body with its mechanical strength and three-dimensional structure. These properties make SWCNTs useful as artery tissueengineering materials for neointima formation and vascular remodeling to cure thrombus. Vascular adventitial fibroblasts (VAFs) play an important role in the process of neointima formation and vascular remodeling. As the major cell type in the vascular adventitia, VAF is not a passive bystander but an active participant in response to diverse stimulations. The transition of VAFs into myofibroblasts (MFs) can traverse the ruptured media and participate in neointimal formation. Similar previous reports showed that CNTs could promote fibroblast to MF transformation. 13, 14 We hypothesized that SWCNTs could be used as artery tissue-engineering materials for promoting VAFs to transform into MFs on the basis of our previous work. Analyses of time-response and concentration-response effects of SWCNTs on VAFs were used to check the hypothesis and elucidate the mechanism using in vitro models.
SM 22 -α is a marker of cell differentiation. VAFs only exist in normal vascular adventitia. After vascular adventitial damage, VAFs differentiate into MFs, which is identified by SM 22 -α in the cytoplasm. Newly differentiated MFs then migrate to the endomembrane and proliferate to become cell components of the new endomembrane. The formation of MFs is closely related with numerous growth factors and cytokines, but TGF-β 1 has the strongest relationship to the formation of MFs. Therefore, we hypothesized that the expression of SM 22 -α is regulated by the TGF-β 1 signal transduction system and Smad family.
The purpose of this study was to investigate the signaling pathway involved in SWCNT-mediated transformation of VAFs and explore the molecular mechanism. We observed VAFs differentiation and morphological changes, and analyzed the effects by monitoring the expression levels of extracellular matrix proteins and other proteins that are involved in MFs differentiation, which will provide new targets for investigation to assess the bioavailability of SWCNTs in artery tissue engineering.
Materials and methods

Cell culture
VAFs were cultured in fibroblast medium (Cell-ling, Heidelberg, Germany) consisting of M199 supplemented with 10% fetal calf serum, 4 mM glutamine, 100 U/mL penicillin and 0.1 mg/mL streptomycin and incubated at 37°C in a humidif ied atmosphere containing 5% CO 2 . Figure 1 shows the original VAFs, as well as morphological ( Figure 1A ) and immunological ( Figure 1B) identification.
SWCNTs characteristics
SWCNTs were purchased from Sigma-Aldrich (St Louis, MO). We used a single tube with a 0.8-1.2 nm diameter and several microns in length, which was determined by TEM (JEM-2010FEF; JEOL, Tokyo, Japan) ( Figure 1C [a]), and the Raman spectrum of the functional groups (RM200; Renishaw, Wotton-under-Edge, UK) is shown in Figure 1C [b]. The chemical components were 93.64% C, 1.64% O, 1.60% Ca, 0.98% Fe, 0.62% Co, 0.50% Cr, 0.41% Si, 0.37% S, and 0.25% Cl.
Dispersion of SWCNTs
To disperse SWCNTs in the culture medium, a stock concentration of 2000 µg/mL SWCNTs was prepared in the appropriate culture medium by vortexing the suspension three times for 5 seconds followed by sonication for 1 minute in an ultrasonic bath (KQ2200DE; Shumei, Jiangsu, China). This procedure was repeated three times. Working concentrations of 200 µg/mL were then prepared by dilution in culture medium. 15 Cell viability assay Nanomaterials, having a small size but large surface area, are able to absorb MTT, which can result in incorrect results. As such, we needed more than one method to detect their cell viability. MTT, WST-1, and WST-8 assays were used in our study to confirm the effect of SWCNTs on cell viability. Briefly, 5 × 10 3 VAFs were seeded into each well of a 96-well plate and grown overnight. Cells were treated in triplicate with the particle suspensions in concentrations of 25 µg/mL, 50 µg/mL, 100 µg/mL, 200 µg/mL, and control in complete culture medium for 24-72 hours. We then discarded the SWCNTs and washed the cells with culture medium. Then, 10 µL of MTT, WST-1, and WST-8 solution were respectively added into 100 µL of complete culture medium, which was added into each well and incubated for 4 hours at 37°C and 5% CO 2 . Mitochondrial dehydrogenases of viable cells reduce the yellowish water-soluble WST-1 and WST-8.
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KCl-SDS assay
The KCl-SDS assay was based on methodology previously described, 16 which was slightly modified in order to detect SWCNT-induced DNA-protein crosslinks (DPCs). Briefly, cells were trypsinized, resuspended, and lysed with 0.5 mL of 2% SDS solution with gentle vortexing. The lysate solution was heated to 65°C, and kept at this temperature for 10 minutes. Then, 0.1 mL of 10 mMTris-HCl (pH 7.4) containing 2.5 M KCl was added. Samples were kept on ice for 5 minutes, and then centrifuged at 10,000 rpm for 5 minutes. The supernatants containing the unbound fraction of DNA were collected into differently labeled tubes. Pellets (containing DPC) were washed with PBS, heated at 65°C for 10 minutes, chilled on ice for 5 minutes, and centrifuged, as described above. Subsequent supernatants following each wash were added with unbound fractions of DNA. The final pellet was resuspended in 1 mL proteinase K solution (0.2 mg/mL soluble in a wash buffer) and digested for 3 hours at 50°C. The resultant mixture was centrifuged at 12,000 rpm for 10 minutes, and the supernatant was collected. Supernatants containing DNA were stained via the fluorescent dye, Hoechst 33258, for 30 minutes in the dark. Fluorescence was measured using a fluorescence multiwell plate reader (VarioskanFlash; Thermo Fisher Scientific, Waltham, MA) at 350/450 nm. Sample DNA contents were quantified relative to a corresponding DNA standard curve generated from calf thymus DNA. The DPC coefficient was measured as a ratio of the percentage of the DNA involved in DPC over the percentage of the DNA involved in DPC plus the unbound fraction of DNA. 
Immunocytochemical staining
Immunocytochemical staining was performed on rat adventitial fibroblasts after SWCNT exposure. Samples were fixed in methanol for 20 minutes, PBS-washed, and permeated with 0.2% Triton X-100 for 5 minutes at room temperature. Then, samples were incubated with 1% normal bovine serum in PBS for 1 hour. Samples were then incubated with primary antibodies, rabbit anti-SM 22 -α IgG (1:2000), PBS-washed, and incubated with FITC-conjugated sheep anti-rabbit-antibodies (1:160). DNA was counter stained with 4,6-diamidino-phenylindole (0.4 µg/mL). Samples were mounted on N-propyl/gallate/glycerol and examined under a fluorescence microscope (Leica Microsystems). All reagents and antibodies were purchased from Sigma-Aldrich.
Western blotting
Total and nuclear protein extracts were prepared in lysis buffer (20 mM Tris-HCl (pH 7.4), 100 mM NaCl, 5 mM EDTA, 2 mM PMSF, 10 ng/mL leupeptin, and 10 µg/mL aprotinin). Protein extracts (40 µg) were separated by SDS-PAGE and transferred onto a polyvinylidenedifluoride membrane (PALL, Port Washington, NY). Membranes were blocked with 5% nonfat milk (Sigma-Aldrich), washed and probed with the following primary antibodies: rabbit anti-rat SM 22 -α, TGF-β1, pSmad2/3, Smad7 and Smad4 (1:500, Santa Cruz, CA) and β-actin (1:1000; Proteintech Group, Chicago, IL). After washing, membranes were incubated with a horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (1:10,000; Sigma-Aldrich) for 2 hours. Then, membranes were washed and developed using an enhanced chemiluminescence kit according to the manufacturer's instructions (Tiangen Biotech, Beijing, China). Western blot assays were repeated at least three times.
Cell ultrastructure changes assessment by TEM
After incubation with 100 µg/mL SWCNTs for 24 hours and 48 hours, cells were observed by TEM. Briefly, VAFs were plated in complete medium (M199) overnight with and without 100 µg/mL SWCNTs. After 12 and 20 hours of incubation at 37°C with 5% CO 2 , cells were detached from the plates with trypsin and pelleted by centrifugation for 6 minutes at 500 g. The supernatant was removed and cell pellets were fixed for 2 hours at 4°C in a mixture of 2% paraformaldehyde and 2% glutaraldehyde in 0.05 M cacodylate buffer (pH 7.3), postfixed in 1% osmium tetroxide for 1 hour at room temperature, dehydrated in ethanol, and embedded in Epon-Araldite. Thin sections were counter stained with uranyl acetate and lead citrate for observation. Each experiment was repeated at least three times.
Statistical evaluation t-Tests
were conducted to analyze the experimental data using Origin 8.0 statistical software (OriginLab, Northampton, MA).
Results
Effect of SWCNTs on cell viability
The MTT, WST-1, and WST-8 assays demonstrated no significant concentration-dependent decrease in VAFs viability following incubation with SWCNTs suspension (25, 50, 100, and 200 µg/mL) for 24, 48, and 72 hours, respectively, as in Figure 1D . Compared to low-dose groups, at the concentration of 200 µg/mL SWCNTs incubation for the same time, the cell viability decreased but was not significantly different (P . 0.05).
Oxidative damage
To investigate the DNA-protein damage, a KCl-sodium dodecyl sulfate (SDS) assay was performed. As in Figure 1E , after incubation with different concentrations of SWCNTs for 72 hours, compared to the control, the increase of the DPCs was not significantly different at the SWCNTs concentrations of 12.5, 25, and 50 µg/mL (P . 0.05) and the increase of DPCs was significantly different at the SWCNTs concentration of 100 µg/mL and 200 µg/mL submit your manuscript | www.dovepress.com
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(P , 0.05 and P , 0.01), which indicated that SWCNTs could lead to VAFs DPCs. Compared to the control group, ROS generation of the 50 µg/mL group was significantly different (P , 0.05), as the concentration of SWCNTs increased to 100 µg/mL and 200 µg/mL, the ROS generation increased (P , 0.01). Figure 2A [a] shows normal cells that were visualized by phase contrast microscopy and appeared spread and flat. SM 22 -α showed a negative distribution. However, cells incubated with 50 µg/mL of SWCNTs for 96 hours showed positive SM 22 -α protein expression (Figure 2A[b] ).
Immunostaining assays
Effects of SWCNTs on cell ultrastructure
Transmission electron microscopy (TEM) revealed the cellular localization of SWCNTs, as shown in Figures 1C  and 2B(a)-(d) . The cell membranes of normal cells exhibited regular contours and a distinct contrast against a moderately stained cytoplasm. In contrast, cells incubated with SWCNTs showed ruffles on their cell membranes, and the cell shape appeared rounded compared with that of normal cells. As shown in Figure 2B [b], aggregated SWCNTs were observed within the cells. After incubation with 100 µg/mL of SWCNTs for 24 and 48 hours, swelling of the nuclear membrane and mitochondrial damage occurred ( Figure 2B [c]) with vacuolar cellular appearance ( Figure 2B[f] ).
C-Jun N-terminal kinase (JNK)/ TgFβ 1 -Smads signal pathway
To approach the molecular mechanism of VAF transformation into MFs promoted by SWCNTs, we measured the relative signal pathway involved in SM 22 -α expression by Western blotting as shown in Figure 3 . Incubated with 50 µg/mL of SWCNTs for 48 hours, the protein of JNK was expressed at high level (P , 0.01) compared to 24 hours but weakened quickly. Under incubation with the same dose of SWCNTs for 72 to 120 hours, the TGF-β 1 protein was up-expressed (P , 0.01) ( Figure 3A [a]). Under incubation with different doses of SWCNTs for 96 hours, the protein levels of TGFβ1, TGFβRII, and SM 22 -α were all obviously increasing with the SWCNTs dose ( Figure 3A[b] ). Compared to the control group, p-Smad2 and p-Smad3 protein levels were both significantly increased after incubation with greater than 12.5 µg/mL SWCNTs for 96 hours, while Smad7 decreased from 3.2 in 200 µg/mL of SWCNTs (P , 0.05 and P , 0.01) ( Figure 3B[a] ) and Smad4 translocated to the nucleus to induce SM 22 -α gene transcription ( Figure 3B[b] ).
Discussion
SM 22 -α is a marker gene of MFs, which encodes a 22 kDa contraction-associated protein. The SM 22 -α gene is characterized by a simple structure and restricted expression in differentiated MFs. Thus, SM 22 -α has been widely used to study the regulatory mechanisms of MF-specific gene expression. Our immunocytochemical study showed that SM 22 -α was expressed after incubation with SWCNTs, which indicated that VAFs transformed into MFs. We used a cell viability assay to assess SWCNTs' biosafety as artery engineering materials. The results showed that SWCNTs had no effect onVAFs at low doses (less than 100 µg/mL), but at the concentration of 200 µg/mL, there was some loss of cell viability. The present result correlates well with the observation of increased ROS generation. Previous reports using various nanomaterials differing in size reflected that SWCNTs can induce significant ROS generation and influence cell viability. Further, loss of cell viability was shown to be due to apoptosis and necrosis by MWCNTs; however, the precise mechanism has yet to be worked out. 13, 14 SWCNTs have been reported to interact with various dyes commonly used to assess cytotoxicity, such as Coomassie blue and Alamar blue. 13, 14 On the other hand, some studies reported that SWCNTs appeared to interact with some tetrazolium salts such as MTT, but not with water-soluble tetrazolium salts such as WST-8, XTT, or INT. Other authors reported that the binding of MTT-formazan to CNT material was found to be negligible and not to influence the results. 19 Thus, we used three methods at the same time to confirm cell viability. The results of the three methods all showed that there is no obvious cytotoxicity for doses of SWCNTs less than 100 µg/mL.
Following 72 hours of cell incubation with SWCNTs, ROS generation was significantly increased, even at a concentration of 50 µg/mL. Furthermore, with increasing concentrations of SWCNTs, ROS generation also increased.
Meanwhile, a cellular response to oxidative stress was triggered. JNKs, also referred to as stress-activated kinases (SAPKs), constitute a subfamily of the mitogen-activated protein kinase (MAPK) superfamily. Oxidative damage induced by a variety of extracellular stimuli (such as stress) is mediated by JNK. Seventy-two hours after incubation with 100 µg/mL of SWCNTs, the number of DPCs significantly increased, binding to the results of JNK high expression at 48 hours after incubation with 50 µg/mL of SWCNTs, indicating that the JNK signal pathway is involved in oxidative damage and the increase in ROS-induced DNA damage.
Our results indicated that TGF-β1 is a multifunctional cytokine, which plays an important role in reparation of tissue damage by enhancing extracellular matrix production and fibroblast proliferation. The TGF-β receptor signaling system is important for regulating differentiation. TGF-β is upregulated by Smad family proteins and the canonical TGF-β signaling pathway involves TGF-β type II/I receptormediated phosphorylation of Smad2/3 that dimerizes with Smad4 and translocates to the nucleus to induce SM 22 The International Journal of Nanomedicine is an international, peerreviewed journal focusing on the application of nanotechnology in diagnostics, therapeutics, and drug delivery systems throughout the biomedical field. This journal is indexed on PubMed Central, MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, Journal Citation Reports/Science Edition, EMBase, Scopus and the Elsevier Bibliographic databases. The manuscript management system is completely online and includes a very quick and fair peer-review system, which is all easy to use. Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.
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to transcribe the SM 22 -α gene, but Smad7 inhibits TGF-β gene expression. Here, we investigated the role of the TGF-β receptor and its downstream Smad signaling components that regulate SM 22 -α expression in response to SWCNT induction of VAF differentiation into MFs. In support of other studies of the brain 20, 21 and lung endothelial cells, 22, 23 activation of the TGF-β receptor pathway was confirmed in our study that showed activation of the canonical Smad signaling pathway by an increase in Smad2/3 phosphorylation and decreased Smad7 levels. Our results showed that JNK was highly expressed instantly at an earlier stage (incubation with SWCNTs for 48 hours) but TGF-β1 expressed in both time-dependent and concentration-dependent manners which indicated that TGF-β1/Smads was the main signal pathway to modulate differentiation of VAFs into MFs induced by SWCNTs.
All the results showed that SWCNTs can be used securely for artery tissue engineering at low doses of less than 50 µg/mL.
